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Background: Rapid changes in lifestyle have led to a global obesity epidemic. Understanding the economic
burden associated with the obesity epidemic is essential to decision making of cost-effective interventions. This
study reviewed costs of obesity and intervention programs in Canada, assessed the scope and quality of existing
cost analyses, and identified implications for economic evaluations and public health decision makers.
Methods: A systematic search of costs associated with obesity or intervention program in Canada between 1990
and 2011 yielded 10 English language articles eligible for review.
Results: The majority of studies was prevalence-based or top-down costing; 40% had excellent quality assessed
using the Quality of Health Economic Study scale. The aggregated annual costs of obesity in Canada ranged from
1.27 to 11.08 billion dollars. Direct costs accounted for 37.2% to 54.5% of total annual costs. Between 2.2% and
12.0% of Canada's total health expenditures were attributable to obesity. The average annual physician cost of
overweight male ($ 427) and female ($ 578) adults was lower than that of obese male ($ 475) and female ($ 682)
adults; this cost differential across weight status groups was comparable to that found in adolescents. The cost for
implementation and maintenance of a school-based obesity prevention program was $ 23 per student.
Conclusions: We observed high costs associated with overweight and obesity and modest costs for obesity
prevention programs; however, no cost-effectiveness study of obesity interventions has been performed in Canada.
Cost-effectiveness analyses of preventive programs that constitute incidence-based life-time modeling of costs and
health outcomes from societal perspective are urgently needed.
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Background
Obesity has rapidly developed into a major global public
health challenge. In Canada, 24% of adults are obese and
the rates of childhood obesity nearly tripled over the last
two decades [1]. Childhood obesity is associated with
obstructive sleep apnea, mental health problems,
asthma, otitis media, and cardiovascular risk factors
[2,3]. Obesity frequently tracks from childhood into
adulthood and increases the risk of developing chronic
diseases, including type 2 diabetes mellitus, cardiovascu-
lar disease and some types of cancer [4]. The negative
health consequences of obesity place a substantial eco-
nomic burden on the health care system and society [5].* Correspondence: bach.tran@ualberta.ca
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reproduction in any medium, provided the orEconomic evidence is indispensable to evaluate the
burden of illness and inform health policy development
[6]. Obesity is associated with poorer health status, more
frequent use of health care services, and increased direct
health care costs [7,8]. Moreover, losses of productivity
and healthy life-years due to absenteeism, co-morbid-
ities, disability, and premature mortality are substantial
indirect costs placed on individuals, their families, and
society [9]. Evaluating the cost of obesity is essential to
facilitate prioritization and resource allocation decisions
on obesity prevention programs [10]. In addition, eco-
nomic evaluations are essential to identify cost-effective
and cost-saving obesity interventions towards the sus-
tainability of the public health systems at provincial and
federal levels [11,12].
There has been a growing body of literature on the as-
sessment of economic burden of obesity in variousd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the economic consequences of childhood obesity on
health care systems [13], obesity costs in different mod-
els of health care systems [5], direct costs of obesity
[14], and the cost-effectiveness of obesity interventions
[12]. However, differences in health care financing and
the heterogeneity in costing approaches hamper compar-
isons across countries, and call for country-specific
reviews. In Canada, specifically, the publicly funded,
single-payer health care system facilitates comprehensive
access to health care services. There have been several
interventions proven effective in controlling childhood
and adulthood obesity [15-17]. While scaling up these
measures is necessary, decision makers are also inter-
ested in economic returns of allocating scare resources
on competing health and social problems [6]. To date,
little evidence is available about the costs, cost-effective-
ness, and cost-savings of these programs in Canadian
settings [6]. The present study is a part of a greater ef-
fort to develop a framework for economic evaluations of
obesity interventions. We aimed to review costs of obes-
ity and intervention programs in Canada, assessed the
scope and quality of existing cost analyses, and identified
implications for economic evaluations and public health
decision makers.Methods
Literature search and study selection
We searched for journal papers, conference abstracts,
and research reports in MEDLINE (via PubMed) and
government or organization’s websites in the period
from 01 January 1990 to 01 May 2012, regardless of their
publication status. We also consulted with experts in the
field to identify additional relevant studies or reports.
The search terms used for PubMed searches are shown
in Table 1. We retrieved the titles and abstracts of these
publications for screening. Reference lists of included
studies were searched for additional potentially eligible
studies. We contacted the authors if there was any
annex or supplemental analysis of the papers that were
not presented.Inclusion criteria and selection of studies
All studies that performed any type of cost analysis (in-
cluding but not limited to cost-of-illness, costs of health
care services or prevention programs) related to excessTable 1 Search strategy
Search terms
(((((cost[Title/Abstract]) OR costing[Title/Abstract]) OR expenditure [Title/Abstr
Abstract]) OR financial[Title/Abstract]) AND obesity[Title/Abstract]) OR overwe
Canada[Title/Abstract]weight in adults or children in Canada were eligible for
inclusion in this review.
Two researchers (B.T. and A.O.) independently reviewed
the retrieved titles and abstracts. For potentially relevant
articles the full-text was obtained and reviewed by both
reviewers for possible inclusion in the study. Disagreement
between reviewers was solved by discussion. No third
party adjudication was necessary.Data extraction and quality appraisal
Full texts of all selected studies were retrieved and data
were extracted using a standardized data extraction
form. The form included study details (authors, year,
and objectives regarding costs), costing approach (scope,
data source, perspective, assumption, and year of cost
determination), results (obesity measures, and cost esti-
mates), strengths and limitations, and the quality scor-
ing. For publications that reported similar results of the
same work, we selected the most comprehensive paper
or report to avoid duplications in the database.
Two researchers (B.T. and A.O.) assessed the quality
of selected studies using the Quality of Health Economic
Studies (QHES) scale [18]. The QHES consists of 16 cri-
teria in the form of Yes/No questions that were selected
by health economics experts. Each question has a
weighted point value that creates a band score between
0 and 100. The QHES has been validated and shown to
be convergent to other instruments such as the British
Medical Journal checklist and the Consensus Health
Economic Criteria list [19,20]. Compared to traditional
non-quantitative classifications of studies’ quality, QHES
is preferable given its summary score constructed by
weighted criteria [18]. The score enables reviewers to
directly compare and rank studies according to their
quality.Data analysis
Data are presented as total costs in Canadian Dollar
(CDN$) (unless stated otherwise) and stratified by age
and sex where available. Quality of studies was rated in-
dependently by two reviewers (B.T. and A.O.). Disagree-
ment between reviewers was solved by discussion. No
third party adjudication was necessary. Since no thresh-
old for interpreting the QHES exists, we arbitrarily set a
score of 90 and above as excellent quality, and a score of
75 to 90 as good quality.Aims Results
act]) OR economic[Title/
ight[Title/Abstract]) AND

































QHES score 82 77 86 94 85 85 85 97 94 91
Year of cost
determination
1994 1997 1997 2000 2000 2001 2005 2006 2006 2009



































































































Data source NPHS 1995/6. Literature
searches




































































Table 2 Profile of selected studies (Continued)
Number of
comorbidities
8 10 8 22 18
Sample size 2,170 28,797 27,478 4,380
Perspective Third-party payer Societal Societal provincial
health system




























































































































































































































































427 (397, 457) $/y,
Female: 578 (542,
613) $/y ; Obese:
Male: 475 (434,
518) $/y, Female:









Total $1.27 B. Direct Costs -
































































2201 (1 449; 3
370) ; Normal
weight: 2147 (1
428; 3 297) ;
Overweight: 2309
(1 463; 3 315) ;
Obese: 2504



























Table 3 QHES score by types of studies
Type of studies n QHES score Classification
Mean SD Min Max Excellent Good
All studies 10 87.1 6.1 77 97 40% 60%
Macro estimates 5 86.0 7.1 77 97 20% 80%
Micro estimates 4 88.8 6.2 82 94 50% 50%
Cost of intervention 1 91
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The literature search was performed in May 2012
(search terms: cost, costing, expenditure, economic, fi-
nancial, obesity, overweight, and Canada). The search
yielded 295 articles from PubMed and 15 research
reports from other internet sources. Applying the inclu-
sion criteria, 10 studies were selected, including nine
cost-of-illness (COI) analyses and one cost analysis of an
obesity prevention program.
Scope of cost analyses
Of 10 cost analyses, there were five federal and five pro-
vincial estimates (Ontario: n=3; Nova Scotia: n=2). The
majority of selected studies examined costs for health
care in adults (n=8), while few evaluated the health care
costs for adolescents (n=1) and children (n=1). There
was only one study that evaluated the costs of an obesity
prevention program in children [21].
Based on the data used, two types of COI analyses can
be differentiated: prevalence-based analyses and incidence-
based analyses. Prevalence-based COI studies determine
the direct cost and production losses attributable to all
cases in a given year while incidence-based COI studies es-
timate the present value of the lifetime costs of an illness
from onset to conclusion for cases first diagnosed within
the study year. The majority of selected studies (n=8) were
prevalence-based COI studies; only one study was an
incidence-based COI analysis [7].
All studies used a top-down approach which multi-
plied health care unit costs by size of population. Five
studies estimated costs at the population level, while the
four other studies analyzed data of individuals. The
scope of all five population estimates included direct
health care costs, and four of them, except Bimingham
et al., also estimated indirect costs, such as losses in
productivity from a societal perspective (Table 2). Of the
four individual analyses, the scope was more focused on
direct medical service costs and health care utilization of
overweight and obese individuals from the perspective of
a provincial health care system (n=2) or the third party
payer (n=2). The studies determined physician costs
(n=4), and health services costs (e.g. costs of hospital
stays or laboratory tests) (n=2). Details of cost compo-
nents included in these analyses are shown in Table 2.
Six of the studies described the thresholds for classify-
ing weight status: five used BMI cut-offs of ≥25 kg/m2
and ≥30 kg/m2 for overweight and obesity, respectively,
while one study used an obesity threshold of BMI
≥27 kg/m2 [22].
Quality of the evidence
The QHES scores ranged from 77 to 97 (Table 3). The pro-
portion of studies of good or excellent quality was 40% and
60%, respectively. A higher average score was seen in healthservices cost analyses (mean ± SD = 88.8 ± 6.2) compared
to COI studies (86.0 ± 7.1). Table 4 illustrates a breakdown
of QHES responses by question. The majority of studies
met quality criteria defined by the QHES; 13/16 criteria
were positively rated in more than 90% studies. The low
positive response rate was seen in the following questions:
Question 5 (50%), “Was uncertainty handled by (1) statis-
tical analysis to address random events, (2) sensitivity ana-
lysis to cover a range of assumptions?”; Question 6 (10%),
“Was incremental analysis performed between alternatives
for resources and costs?”; Question 16 (70%), “Was there a
statement disclosing the source of funding for the study?”.
The corresponding scores of question 5, 6, and 16 in the
total QHES score was 9, 6, and 3, respectively.Costs analyses of obesity and obesity prevention programs
Table 5 summarizes the economic burden of overweight
and obesity in the Canadian settings. The aggregated an-
nual costs of obesity in Canada ranged from 1.27 to
11.08 billion dollars. In those studies that presented both
direct and indirect costs, the total direct costs accounted
for 37.2% to 54.5% of total annual costs. In most studies,
direct and indirect costs accounted for approximately 2
to 4% of the total health care expenditure. Noticeably,
Patra et al. estimated the total costs of obesity ranged
from 2.4% to 12% of total health care expenditure in
Canada in 1997 [23].
In health service costs analyses, the average annual
physician cost of overweight male ($ 427) and female
($ 578) adults was lower than that of obese male ($ 475)
and female ($ 682) adults in 2000; this cost differential
across weight status groups was comparable to that
found in adolescents [8]. Costs for physician services
were estimated to increase by $ 9 for each unit increase
in BMI in 1994 [24]. Tarride et al. estimated the phys-
ician, hospitalization and day procedures costs of normal
weight, underweight, overweight, and obese adults in
2000 to be $ 708, $ 746, $ 690 and $ 884. Kuhle et al.
reported the 2006 physician costs of normal weight,
overweight, and obese children to be $ 275, $ 298, and
$ 356, respectively [7].
In the only cost analysis of a school-based obesity pre-
vention program in Canada, Ohinmaa et al estimated
the costs for the school board-wide implementation and
Table 4 Percentage of responses by QHES question
QHES %
Reponses
1 Was the study objective presented in a clear, specific, and measurable manner? 100%
2 Were the perspective of the analysis (societal, third-party payer, etc.) and reasons for its selection stated? 100%
3 Were variable estimates used in the analysis from the best available source (i.e., randomized control trial - best, expert opinion -
worst)?
100%
4 If estimates came from a subgroup analysis, were the groups prespecified at the beginning of the study? 100%
5 Was uncertainty handled by (1) statistical analysis to address random events, (2) sensitivity analysis to cover a range of assumptions? 50%
6 Was incremental analysis performed between alternatives for resources and costs? 10%
7 Was the methodology for data abstraction (including the value of health states and other benefits) stated? 100%
8 Did the analytic horizon allow time for all relevant and important outcomes? Were benefits and costs that went beyond 1 year
discounted (3% to 5%) and justification given for the discount rate?
100%
9 Was the measurement of costs appropriate and the methodology for the estimation of quantities and unit costs clearly described? 90%
10 Were the primary outcome measure(s) for the economic evaluation clearly stated and did they include the major short-term was
justification given for the measures/scales used?
100%
11 Were the health outcomes measures/scales valid and reliable? If previously tested valid and reliable measures were not available,
was justification given for the measures/scales used?
100%
12 Were the economic model (including structure), study methods and analysis, and the components of the numerator and
denominator displayed in a clear, transparent manner?
90%
13 Were the choice of economic model, main assumptions, and limitations of the study stated and justified? 100%
14 Did the author(s) explicitly discuss direction and magnitude of potential biases? 100%
15 Were the conclusions/recommendations of the study justified and based on the study results? 100%
16 Was there a statement disclosing the source of funding for the study? 70%
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school and $ 23 per student [21].Relative Risks (RR) and Population Attributable Fractions
(PARF) of Obesity-related diseases
Estimates of relative risks and population attributable
fractions of health conditions associated with overweight
and obesity are key components of COI studies. The
number of obesity-related health conditions ranged from
8 to 22 in the five COI studies. RRs and PARFs of 18
related-health conditions compiled by Anis et al. wereTable 5 Summary of economic burden of excess weight in Ca






Canada, 1997 10 1.800
Alberta, 2005 22 0.630 49.5%
Canada, 2001 7 1.600 37.2%




Nova Scotia, 2006 0.295
Canada, 1997 11.082the most comprehensive estimates among those access-
ible detailed analyses [11].Discussion
We reviewed studies that evaluated the costs of over-
weight and obesity and costs of prevention programs to
inform the design of economic evaluations of obesity
interventions in Canada. The findings indicate that the
economic burden of obesity is substantial and requires
swift and comprehensive public health action. The frac-
tion of total health care costs attributable to overweightnadian settings
Indirect
cost
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12%. By contrast, there is scarce data on the costs of
obesity prevention interventions in Canada to inform eco-
nomic evaluations and to aid resource allocation deci-
sions. The included cost analysis of a comprehensive
school health program in Nova Scotia showed that this
intervention was not resource-intensive compared to the
costs of programs in other countries: For example, Carter
et al. estimated the costs of various school-based obesity
prevention programs in Australia to be in the range of
AUS$ 28 to AUS$ 473 per student. It is important to
stress that the cost of obesity treatment is considerably
higher than the prevention costs. The former was esti-
mated to be between AUS $ 650 to AUS $ 31,553 depend-
ing on the type of therapy [25]. A recent review by John
et al. found heterogeneity in cost-effectiveness analyses
and study quality of obesity interventions, which hampers
comparison of data from different settings [10,12]. There-
fore, costing should be integrated at the implementation
of prevention projects and the resulting data should be
made accessible for cost-effectiveness analyses.
We assessed the quality of cost analyses using the
QHES and found a lack of uncertainty handling and in-
cremental analyses as the main shortcomings of the
reviewed studies. In addition, most studies did not
clearly present the unit costs of obesity-related chronic
conditions that limits the comparison across settings.
The approach used in estimating the economic burden
of obesity based on the population-attributable risks of
co-morbidities is similar to previous works but the
method has some drawbacks. The included COI analyses
assumed that co-morbidities were mutually exclusive,
and their relative risks were estimated mostly from data
outside Canada.
This review identified several implications for future
research. First, more bottom-up COI analyses and pro-
gram costs analyses in Canadian settings are needed to
guide economic evaluation of and resource allocation for
obesity prevention programs. Costs analyses should in-
clude more detailed stratifications, (e.g., by sex and age),
and uncertainty analysis should be used. Second, a sys-
tematic synthesis and estimate of parameters, for in-
stance, likelihood of developing obesity overtime or unit
costs of co-morbidities, using national surveys data are
essential to improve the comparability and generalizability
of future COI or economic evaluation studies. Finally, mod-
eling the incidence-based lifetime costs and outcomes in-
cluding direct and indirect costs from a societal perspective
are essential to perform economic evaluation studies of
obesity prevention programs.
We found heterogeneity in the scopes of cost analyses,
including types of costs, numbers and types of related
comorbidities, and BMI thresholds used. These inconsis-
tences made it difficult to compare studies in differentsettings or to evaluate changes in economic burden of
overweight and obesity over time. In addition, several types
of costs were not determined, such as the out-of-pocket
payment of households and individuals, or the costs of ab-
senteeism to employers and employees. The varying scope
of these cost analyses reflects the availability and accessibil-
ity of data sources at national and provincial levels. At the
national level, Canadian Community Health Survey, Na-
tional Population Health Survey and Economic Burden of
Illness in Canada have good information to estimate the
prevalence of obesity and its associated health care use and
costs. To weigh future savings in health care costs against
the costs for an obesity prevention program, an incidence-
based COI analysis is required to estimate lifetime costs
associated with weight status. A bottom-up costing ap-
proach and simulations using decision-analytical models
are also necessary. None of the reviewed papers used longi-
tudinal national data to estimate the changes in obesity or
attempted to project total lifetime costs of obesity. This is
partly due to the lack of longitudinal Canadian data on the
development of weight-related health conditions and costs
[26]. Nonetheless, the national data sources listed above
might be used to project the changes in obesity epidemic
at a population level. Further efforts to fully capture longi-
tudinal changes in BMI trajectories and life-time costs are
needed prior to economic evaluations of interventions for
the prevention of obesity.
This review showed that indirect costs of obesity were
substantial and account for about 45 to 60% of the total
costs. Therefore, focusing solely on direct medical costs of
obesity-related comorbidities does not fully capture the
economic burden of the obesity epidemic. Estimating costs
and monetary benefits from a societal perspective in an
economic evaluation may provide a more complete picture.
Our review found only one cost analysis of a compre-
hensive school health program in Canada. The cost ana-
lysis was a 1-year assessment using a top-down approach.
The paucity of data highlights the urgent need for cost
analyses of existing and new prevention programs. When
conducting an economic evaluation of an obesity preven-
tion, considering only the savings due to reductions in ex-
cess weight does not provide a complete picture of the
effect of the program. Some interventions may not change
the weight status of individuals, but may still improve
health status and ability to work. Second, reductions of
health services utilization and health care costs as a result
of an intervention might also be substantial. Conse-
quently, in the design of an economic evaluation, the
changes in costs and outcomes under intervention would
also provide important additional information.
Conclusions
To conclude, we observed high costs associated with
overweight and obesity and modest costs for obesity
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study of obesity interventions has been performed in
Canada. Cost-effectiveness analyses of preventive pro-
grams that constitute incidence-based life-time model-
ing of costs and health outcomes from societal perspective
are urgently needed.
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